The Anti-Thrombotic Effects of PCSK9 Inhibitors
Atherosclerosis is the primary process that underlies cardiovascular disease. The connection between LDL cholesterol and the formation of atherosclerotic plaques is established by solid evidence. PCSK9 inhibitors have proven to be a valuable and practical resource for lowering the LDL cholesterol of...
Main Authors: | Martin Jozef Péč, Jakub Benko, Jakub Jurica, Monika Péčová, Marek Samec, Tatiana Hurtová, Tomáš Bolek, Peter Galajda, Martin Péč, Matej Samoš, Marián Mokáň |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/9/1197 |
Similar Items
-
Unilateral upper and lower limb ischemia mimics stroke: a case report
by: Monika Péčová, et al.
Published: (2024-02-01) -
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
by: Peter Blaško, et al.
Published: (2022-12-01) -
COVID-19 and the Response to Antiplatelet Therapy
by: Tomáš Bolek, et al.
Published: (2023-03-01) -
A Systematic Approach to Assess the Activity and Classification of PCSK9 Variants
by: Kepa B. Uribe, et al.
Published: (2021-12-01) -
Application of Liquid Chromatography Coupled to Mass Spectrometry for Direct Estimation of the Total Levels of Adenosine and Its Catabolites in Human Blood
by: Jakub Šofranko, et al.
Published: (2024-03-01)